Eurazeo Crecimiento futuro

Future controles de criterios 2/6

Se prevé que los beneficios de Eurazeo disminuyan en un 25.1% al año, mientras que se espera que sus ingresos anuales crezcan en un 33.3% al año. Se prevé que el BPA disminuya en un 23.8% por año. Se espera que la rentabilidad financiera sea de 8.8% en 3 años.

Información clave

-25.1%

Tasa de crecimiento de los beneficios

-23.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Diversified Financial	15.8%
Tasa de crecimiento de los ingresos	33.3%
Rentabilidad financiera futura	8.8%
Cobertura de analistas	Low
Última actualización	05 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

ENXTPA:RF - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1,639	771	1,045	N/A	2
12/31/2025	1,479	664	1,351	1,686	2
12/31/2024	1,225	599	1,074	1,514	2
12/31/2023	405	1,824	-24	-12	N/A
9/30/2023	1,994	2,156	10	150	N/A
6/30/2023	3,583	2,488	44	311	N/A
3/31/2023	4,615	1,542	-73	282	N/A
12/31/2022	5,646	595	-190	254	N/A
9/30/2022	5,894	801	-227	165	N/A
6/30/2022	6,142	1,007	-265	76	N/A
3/31/2022	6,450	1,294	-103	196	N/A
12/31/2021	6,759	1,580	58	316	N/A
9/30/2021	6,051	1,142	64	310	N/A
6/30/2021	5,343	703	70	304	N/A
3/31/2021	4,881	271	69	303	N/A
12/31/2020	4,419	-161	69	301	N/A
9/30/2020	4,385	-303	200	416	N/A
6/30/2020	4,352	-444	330	531	N/A
3/31/2020	4,748	-165	264	505	N/A
12/31/2019	5,143	114	197	480	N/A
9/30/2019	5,125	193	109	409	N/A
6/30/2019	5,106	271	21	338	N/A
3/31/2019	5,013	280	7	290	N/A
12/31/2018	4,920	289	-7	242	N/A
9/30/2018	4,795	394	-36	184	N/A
6/30/2018	4,671	499	-66	125	N/A
3/31/2018	4,344	490	-31	161	N/A
12/31/2017	4,017	481	5	196	N/A
9/30/2017	4,026	552	N/A	177	N/A
6/30/2017	4,036	624	N/A	158	N/A
3/31/2017	3,522	575	N/A	148	N/A
12/31/2016	3,009	525	N/A	138	N/A
9/30/2016	3,097	302	N/A	N/A	N/A
6/30/2016	1,389	79	N/A	42	N/A
3/31/2016	2,588	678	N/A	-139	N/A
12/31/2015	3,788	1,277	N/A	-319	N/A
9/30/2015	3,721	1,276	N/A	N/A	N/A
6/30/2015	5,452	1,276	N/A	134	N/A
3/31/2015	4,785	593	N/A	262	N/A
12/31/2014	4,118	-89	N/A	390	N/A
9/30/2014	4,255	25	N/A	522	N/A
6/30/2014	4,392	139	N/A	655	N/A
3/31/2014	4,817	350	N/A	663	N/A
12/31/2013	5,243	561	N/A	671	N/A
9/30/2013	5,146	409	N/A	683	N/A
6/30/2013	5,049	257	N/A	694	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de RF disminuyan en los próximos 3 años (-25.1% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de RF disminuyan en los próximos 3 años (-25.1% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de RF disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (33.3% al año) de RF crezcan más rápidamente que los del mercado French (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (33.3% al año) de RF crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de RF sea baja dentro de 3 años (8.8%).

Eurazeo Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to €89.79

Consensus forecasts updated

Consensus forecasts updated

Price target increased to €80.63

Recent updates

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

If EPS Growth Is Important To You, Eurazeo (EPA:RF) Presents An Opportunity

There Is A Reason Eurazeo SE's (EPA:RF) Price Is Undemanding

Eurazeo SE, Annual General Meeting, May 07, 2024

Does Eurazeo (EPA:RF) Deserve A Spot On Your Watchlist?

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

First half 2023 earnings released: EPS: €25.36 (vs €1.33 loss in 1H 2022)

Should You Be Adding Eurazeo (EPA:RF) To Your Watchlist Today?

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

We Ran A Stock Scan For Earnings Growth And Eurazeo (EPA:RF) Passed With Ease

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

Consensus forecasts updated

Consensus forecasts updated

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Price target decreased to €89.79

Here's Why We Think Eurazeo (EPA:RF) Is Well Worth Watching

First half 2022 earnings released

Consensus forecasts updated

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Consensus forecasts updated

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Price target increased to €80.63

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Should Eurazeo SE (EPA:RF) Be Part Of Your Income Portfolio?

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Price target increased to €69.86

Eurazeo SE Announces Its Intention to Resume Distribution

Price target raised to €68.75

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €63.35

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

Investors Who Bought Eurazeo (EPA:RF) Shares Five Years Ago Are Now Up 48%

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.85

New 90-day high: €57.35

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

What Can We Make Of Eurazeo's (EPA:RF) CEO Compensation?

New 90-day high: €56.20